What they were paid
Travere Therapeutics Director Compensation Table · all 5 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $70,000 | $137,475 | $412,425 | $0 | $619,900 |
| FY2024 | $70,000 | $44,330 | $132,990 | — | $247,320 |
| FY2023 | $68,750 | $76,995 | $230,985 | — | $376,730 |
| FY2022 | $65,000 | $64,140 | $192,420 | — | $321,560 |
| FY2021 | $65,000 | $54,810 | $164,430 | — | $284,240 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Travere Therapeutics, Inc. DEF 14A filed April 6, 2026, accession 0001438533-26-000027, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Travere Therapeutics, Inc. filed document, accession 0001438533-26-000027. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2026.
Get the Travere Therapeutics Board Governance Report
$619,900 Roy Baynes, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 6, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Travere Therapeutics pays directors a $50,000 cash retainer and $549,900 in equity.
Committees
FY2025 · as the proxy prints themNominating/Governance · Science & Medical Technology (Chair)
The rest of the Travere Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Eric Dube | Director | — |
| Gary Lyons | Independent Director | $638,650 |
| Jeffrey Meckler | Independent Director | $621,900 |
| John A. Orwin | Independent Director | $618,650 |
| Ron Squarer | Independent Director | $609,900 |
| Ruth Williams-Brinkley | Independent Director | $609,275 |
| Sandra Poole | Independent Director | $612,400 |
| Suzanne Bruhn | Independent Director | $616,775 |
| Timothy Coughlin | Independent Director | $629,275 |
The full Travere Therapeutics compensation record
free company briefThis page is one director within Travere Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Travere Therapeutics proxy · each links to its own free briefOrder TVTX
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.